The Pharmaceutical CDMO and CRO Services industry on FinBizNet covers 11 listed companies, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.
| Listed companies | 11 |
|---|---|
| Combined market cap | ₹4,05,816 Cr |
| Median P/E (profitable companies) | 65.3 |
| Median return on equity | 10.1% |
| Companies with latest quarterly results | 11 of 11 |
| Company | Market Cap | P/E | ROE | Quarterly Revenue | Quarterly Net Profit | Quarter |
|---|---|---|---|---|---|---|
| Divis Laboratories Limited | ₹2,40,249 Cr | 93.6 | 16.2% | ₹3,080 Cr | ₹902 Cr | Q1 FY27 |
| Anthem Biosciences Limited | ₹46,309 Cr | 78.8 | 19.4% | ₹418 Cr | ₹120 Cr | Q1 FY27 |
| Sai Life Sciences Limited | ₹30,701 Cr | 88.0 | 15.1% | ₹554 Cr | ₹73 Cr | Q1 FY27 |
| Cohance Lifesciences Ltd | ₹17,735 Cr | 99.0 | 5.1% | ₹422 Cr | ₹-45 Cr | Q1 FY27 |
| Onesource Specialty Pharma Limited | ₹16,023 Cr | — | -1.3% | ₹516 Cr | ₹57 Cr | Q2 FY27 |
| Jubilant Pharmova Ltd | ₹14,860 Cr | 37.4 | 6.0% | ₹2,229 Cr | ₹56 Cr | Q1 FY27 |
| Syngene International Ltd. | ₹14,326 Cr | 45.7 | 6.6% | ₹736 Cr | ₹-9 Cr | Q1 FY27 |
| Concord Biotech Ltd | ₹13,717 Cr | 52.6 | 13.5% | ₹257 Cr | ₹56 Cr | Q1 FY27 |
| Blue Jet Healthcare Ltd | ₹9,191 Cr | 34.0 | 19.9% | ₹293 Cr | ₹78 Cr | Q1 FY27 |
| Dishman Carbogen Amcis Ltd | ₹2,177 Cr | 22.3 | 1.6% | ₹678 Cr | ₹-58 Cr | Q1 FY27 |
| Rays of Belief Limited | ₹528 Cr | 78.0 | — | ₹25 Cr | ₹3 Cr | Q1 FY27 |
Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL).
FinBizNet tracks 11 listed companies in the Pharmaceutical CDMO and CRO Services industry, including Divis Laboratories Limited, Anthem Biosciences Limited, Sai Life Sciences Limited, Cohance Lifesciences Ltd, Onesource Specialty Pharma Limited, Jubilant Pharmova Ltd, Syngene International Ltd., Concord Biotech Ltd, among others.
By market capitalisation, the largest Pharmaceutical CDMO and CRO Services companies are Divis Laboratories Limited (₹2,40,249 Cr), Anthem Biosciences Limited (₹46,309 Cr), Sai Life Sciences Limited (₹30,701 Cr), Cohance Lifesciences Ltd (₹17,735 Cr), Onesource Specialty Pharma Limited (₹16,023 Cr).
The 11 Pharmaceutical CDMO and CRO Services companies tracked on FinBizNet have a combined market capitalisation of about ₹4,05,816 Cr.
The median price-to-earnings ratio across 10 profitable Pharmaceutical CDMO and CRO Services companies is 65.3, and the median return on equity across the industry is 10.1%. Medians are shown for context only.
FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Pharmaceutical CDMO and CRO Services industry.